For decades, opinion polls have shown that the British public feels that the UK National Health Service (NHS) is underfunded. The latest British Social Attitudes Survey for 2000 is typical of many over the years, indicating that around 50-60% of the sample would like to see increases in health care spending as a priority over other government spending programmes -with a similar proportion prepared to pay more tax in order to fund extra spending. I Following the Wanless review of NHS funding over the next 20 years, commissioned by the Chancellor of the Exchequer.f the 2002 Budget set out the government's NHS spending plans for the next five years. Historically, the scale of the announced increase is unprecedented: a cash rise from around £65 billion today to £106 billion in 2007/8an increase in real terms of over 40%, which would see total (public and private) health care spending increase from 7.7% of GDP this year to over 9.4% in 2007/8. This increase will be wholly fuelled by increased public spending on the NHS and financed through tax increases. One must presume that, in answering the pollsters, the public was aware of the ancient Chinese proverb: 'Be careful what you wish for -it might come true'! British government ministers now feel that they are in step with public opinion and have fulfilled their part of the deal: [as they have not quite said, but have intimatedJ now it's the turn of the NHS to deliver more and better services to improve quality, reduce waiting times and, in particular, improve the nation's health.
After paying for increases in pay and prices, more money for health care will certainly mean more doctors, nurses, beds, drugs and equipment. And extra money for capital investment along with the onward march of the Private Finance Initiative will mean newer infrastructure. Labour and capital will combine to enable more patients to be treated, in better surroundings, after having waited less time to get into the health care system. But will more money for health care buy more health?
Such a question raises others. A prior question is: Does health care produce health? Furthermore, how cost-effective is investment in health care (as opposed, say, to investment in non-health care activities that produce health)? A further question might be: Is the outcome of health care (healthiness) all that is valued, or should the process of care also be taken into account? A complicating twist is whether the relationship between health and health care works both ways: do improvements in health (as the Wanless review assumed) reduce the need for health care spending? On this last question, experience suggests that improvements in health have not reduced the need (or is it desire?) to spend more on health care. Pressures to spend more arise from, for example, advances in medical technology and the creeping expansion of medicine into areas of human life and conditions previously untouched by the surgeon's knife.
Spending more on health care does seem to be. associated with higher levels of health. For example, cross-sectionally, in a simple model of the association between countries' per capita health care spending and healthy life-expectancy at birth (to take one population health measure -others could be substituted), a curve can be fitted which, as health care spending increases, rises steeply and then begins to flatten. Depending on where a country lies on the curve, the marginal returns to investment in health care seem to vary considerably.' A 10% increase in health care spending per capita in the UK would, on the basis of this relationship, suggest an increase in life-expectancy of just 0.5% (around four months). Conversely, for Mozambique, the same percentage increase in health care spending would suggest an increase in healthy life-expectancy of 37% (around 11 years).
So, for the Chancellor's investment of around £40 billion in the NHS over the next five years, we could perhaps look forward to an increase in average healthy life-expectancy of around 1.7 years. Pushing this (back of the envelope) calculation to its limits (if not beyond), if all the three million or so babies born over the next five years were to enjoy an extra 1.7 years of life, the cost per healthy life-year would be of the order of around £8000a figure that would compare favourably with the cost per quality-adjusted life-year gained reported for health technologies so far approved for funding by the English National Institute for Clinical Effectiveness.
But, clearly, finance for services is only one of a number of factors determining population health measures such as healthy life-expectancy; from a false premise (or simplistic, under-and mis-specified model), any conclusion is possible. We know, for example, that the level of a country's health care spending is associated with that country's level of wealth and that health care is a luxury good which, as the country's wealth increases, increasingly becomes the purchase of choice. And, through a variety of non-health care mechanisms, as wealth increases, so too does health. But numerous cross-country studies of the determinants of health suggest that, while the 'wealth variable', such as per capita GDP, tends to be positively correlated with health, virtually all permutations of health care spending (share of GDP, per capita spend, etc.) tend to contribute little to explaining variations in countries' health.v''
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Yet other studies suggest that health care spending is an important and significant factor in explaining variations in health across countries, regions and over time. Wang, for example, shows that, for 60 low-income countries, health share of GDP (but, interestingly, not per capita health care spend) is significant for health." Wolfe's analysis of six developed countries supports this view, arguing that there is a positive link between health care expenditure and health, but that 'this says nothing about whether money is better spent influencing lifestyle ... or medical expenditures."
An attempt to tease out these factors has been made by Or in a production function study of 21 OECD countries.? Or used non-monetary measures of health care supply, together with other health care and nonhealth care variables, to explain variations in a number of population health measures and showed that health care (doctors per 1000 population), institutional factors (e.g. the existence of gatekeeping) and non-health care variables (e.g. GDP per capita) were all positively associated with health. However, Or's study suffers from uncontrolled multi-collinearity problems among the independent variables, as well as the inherent inability of the statistical technique to unambiguously identify casual relationships or the actual mechanism giving rise to the statistical associations discovered.
A different approach to the 'What's health care ever done for health?' question has been pursued by John Bunker. 10,1I Rather than the cross-country, top-down statistical approach, Bunker attempted to explain health care's contribution to changes in (US) health (lifeexpectancy) by aggregating the impact on health of a range of health care services (as measured by clinical trials, for example). The high-level conclusion from this 'inventory' approach was that, across the US population, health care had added around five years to lifeexpectancy between 1900 and 1990, with a potential for another two years (if, for example, all those who could have benefited from care had actually received it). These are not insignificant gains out of an increase in life-expectancy of around 30 years since the beginning of the 20th century. What's more, given medical progress since the 1970s, health care's contribution to health improvements appears to be increasing. 10 Similar studies focusing on conditions amenable to health care interventions also indicate that health care has a positive impact on health. 12 ,13 Reconciling the results from all these approaches investigating the impact of health care on health is difficult. Many studies suffer from methodological, data quality and sample size problerns.!" Although some of these problems can be dealt with through appropriate statistical methods, the complexity of the interaction between health determinants makes accurate isolation of the effects of anyone factor extremely difficult. This has led some to query whether unambiguously quantifying the impact of health care on health (relative to alternative uses of resources as well as in absolute terms) is possible.P So, contrary to the usual plea of the academic in need of extra funding, the dead-end, if frustrating, conclusion is that perhaps more research is not needed.
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